Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterization of Somatic Structural Variants in Diffuse Gliomas over Disease Progression and Treatment
EF 2021-22
Résumé
Diffuse glioma is an aggressive type of brain tumour that arises from glial or precursor cells. It is the most common type of brain malignancies diagnosed in adults, characterized by high recurrence rates and treatment resistance. It has been previously shown that the ineffectiveness of treatments for glioma is primarily a result of intertumoural genetic heterogeneity. Previous studies have characterized single-nucleotide variants (SNVs) and small deletions/insertions in the genome of gliomas that give rise to its genetic heterogeneity, but have yet included large structural variants (SVs: deletions, insertions, tandem duplications) in their analysis. To advance our understandings of how SVs contribute to the genetic heterogeneity in gliomas, we performed linked-reads whole-genome sequencing (LRWGS) and single-nuclei RNA sequencing (snRNA-seq) on 36 patient samples of primary and recurrent gliomas. Data generated from LRWGS contains not only the DNA sequence of the bulk tumour with mapped SNVs, but also SVs and phased haplotypes of the genome. Our analysis identified around 500 candidate somatic structural variants in the coding and non-coding regions of the genome in each sample, and they have been thoroughly annotated. Genomic alterations of interest identified from the LRWGS data are then cross-validated in the snRNA-seq data to elucidate their effects in the context of the transcriptome and cellular functions of the malignant cells. Our dataset and analyses of the sequencing data from gliomas would comprehensively characterize the role of SVs in gliomas and provide a source for the discovery of new molecular targets that originate from SVs.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466958
Name
Tian Ryan Yu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of Somatic Structural Variants in Diffuse Gliomas over Disease Progression and Treatment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Computational Biology; Diffuse Glioma; Genomics; Long-Read Sequencing; Structural Variants; Transcriptomics
Abstract
Diffuse glioma is an aggressive type of brain tumour that arises from glial or precursor cells. It is the most common type of brain malignancies diagnosed in adults, characterized by high recurrence rates and treatment resistance. It has been previously shown that the ineffectiveness of treatments for glioma is primarily a result of intertumoural genetic heterogeneity. Previous studies have characterized single-nucleotide variants (SNVs) and small deletions/insertions in the genome of gliomas that give rise to its genetic heterogeneity, but have yet included large structural variants (SVs: deletions, insertions, tandem duplications) in their analysis. To advance our understandings of how SVs contribute to the genetic heterogeneity in gliomas, we performed linked-reads whole-genome sequencing (LRWGS) and single-nuclei RNA sequencing (snRNA-seq) on 36 patient samples of primary and recurrent gliomas. Data generated from LRWGS contains not only the DNA sequence of the bulk tumour with mapped SNVs, but also SVs and phased haplotypes of the genome. Our analysis identified around 500 candidate somatic structural variants in the coding and non-coding regions of the genome in each sample, and they have been thoroughly annotated. Genomic alterations of interest identified from the LRWGS data are then cross-validated in the snRNA-seq data to elucidate their effects in the context of the transcriptome and cellular functions of the malignant cells. Our dataset and analyses of the sequencing data from gliomas would comprehensively characterize the role of SVs in gliomas and provide a source for the discovery of new molecular targets that originate from SVs.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tian, Ryan Yu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~